Healthcare -
Biotechnology - NASDAQ - US
$ 40.74
4.25 %
$ 7.57 B
Market Cap
-11.38
P/E
RVMD - STOCK-BASED COMPENSATION
Stock-based Compensation RVMD - Revolution Medicines, Inc.
61.8 M
LAST VALUE
72.65%
2 YEAR CAGR
135.38%
5 YEAR CAGR
0.00%
10 YEAR CAGR